Matthew Maxwell Donley, Ex VP, Intern'l Operations at Aurinia Pharmaceuticals Inc. (AUPH), bought 9,900 shares at $10.07 ($100K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AUPH | BUY | 2022-11-23 | $47K | — | Filing → |
| AUPH | SELL | 2022-03-04 | $37K | — | Filing → |